Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2026-01-03 @ 10:21 PM
Study NCT ID:
NCT01951157
Status:
COMPLETED
Last Update Posted:
2019-09-24
First Post:
2013-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients
Sponsor:
PharmaMar
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PM1183-B-004-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None